Clinical Trials · NCT01694498
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Men
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 183
- Start date
- Sep 2012
- Locations
- 35 sites, Japan
- Primary endpoint
- Change from baseline in mean number of nocturnal voids